Thomas G. Johnson

628 total citations · 1 hit paper
9 papers, 484 citations indexed

About

Thomas G. Johnson is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Thomas G. Johnson has authored 9 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Thomas G. Johnson's work include Occupational and environmental lung diseases (7 papers), Genetic factors in colorectal cancer (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Thomas G. Johnson is often cited by papers focused on Occupational and environmental lung diseases (7 papers), Genetic factors in colorectal cancer (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Thomas G. Johnson collaborates with scholars based in Australia, Austria and New Zealand. Thomas G. Johnson's co-authors include Norbel Galanti, Tatiana B. Gasic, G Gasic, Scott Murphy, Glen Reid, Nico van Zandwijk, Karin Schelch, Andrew Burgess, Sunali Mehta and Walter Berger and has published in prestigious journals such as International Journal of Cancer, Cancer Letters and Cancers.

In The Last Decade

Thomas G. Johnson

8 papers receiving 457 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant disease

1973 357 citations G Gasic, Tatiana B. Gasic et al. International Journal of Cancer profile →

Peers

Countries citing papers authored by Thomas G. Johnson

Since Specialization

Citations

This map shows the geographic impact of Thomas G. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Johnson more than expected).

Fields of papers citing papers by Thomas G. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Johnson. The network helps show where Thomas G. Johnson may publish in the future.

Co-authorship network of co-authors of Thomas G. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Johnson. A scholar is included among the top collaborators of Thomas G. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Johnson. Thomas G. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo 2023 ·Cancer Letters ·Karin Schelch, (unknown), (unknown), Thomas G. Johnson, Verena Kopatz, (unknown), (unknown), (unknown), Petra Heffeter, Mir Alireza Hoda, Konrad Höetzenecker, Balázs Döme, Walter Berger, Glen Reid, Michael Grusch	12
2	YB ‐1 regulates mesothelioma cell migration via snail but not EGFR , MMP1 , EPHA5 or PARK2 2022 ·Molecular Oncology ·Karin Schelch, (unknown), (unknown), (unknown), Thomas G. Johnson, (unknown), (unknown), Caterina Sturtzel, (unknown), (unknown), Konrad Höetzenecker, Mir Alireza Hoda, Walter Berger, Martin Distel, Balázs Döme, Glen Reid, Michael Grusch	2
3	Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future 2020 ·Frontiers in Oncology ·Glen Reid, Thomas G. Johnson, Nico van Zandwijk	32
4	YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms 2020 ·Cancers ·Thomas G. Johnson, Karin Schelch, Kaitao Lai, (unknown), Marina Kennerson, Michael Grusch, Glen Reid, Andrew Burgess	8
5	Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma 2019 ·Frontiers in Cell and Developmental Biology ·Thomas G. Johnson, Karin Schelch, Sunali Mehta, Andrew Burgess, Glen Reid	25
6	Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma 2019 ·FASEB BioAdvances ·Xiyong Fan, (unknown), Cleo Robinson, (unknown), Karin Schelch, Thomas G. Johnson, Nico van Zandwijk, Glen Reid, Anthony M. George	5
7	Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma 2017 ·Journal of Thoracic Oncology ·Thomas G. Johnson, Karin Schelch, Yuen Yee Cheng, Marissa Williams, (unknown), Michaela B. Kirschner, Steven Kao, Anthony Linton, Sonja Klebe, Brian C. McCaughan, Ruby C.Y. Lin, Christine Pirker, Walter Berger, Annette Lasham, Nico van Zandwijk, Glen Reid	43
8	Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant disease breakdown → 1973 ·International Journal of Cancer ·G Gasic, Tatiana B. Gasic, Norbel Galanti, Thomas G. Johnson, Scott Murphy	357
9	Wills, Trusts and Estates 1970 ·Virginia Law Review ·(unknown), Thomas G. Johnson	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact